Investment
Features
FeesSafety
Academy
More
Pluang+

Smartsheet sued for secretly buying back shares amid takeover talks at premium price.

Market News
07 Aug 2026
PRNewsWire
View Source
Bearish
Smartsheet sued for secretly buying back shares amid takeover talks at premium price.

A securities class action lawsuit was filed against Smartsheet Inc. alleging the company repurchased over 1.1 million shares from investors between June and August 2024 without disclosing ongoing acquisition talks with Blackstone and Vista Equity Partners. The lawsuit claims Smartsheet's board knew about a premium buyout offer but failed to inform shareholders while promoting share buybacks, misleading investors and violating federal securities laws. When the acquisition was announced at $56.50 per share, Smartsheet's stock price rose sharply, revealing the previously undisclosed premium offer. Investors who sold shares during this period and suffered losses may have legal rights, with a deadline to seek lead plaintiff status by October 5, 2026.

More News

Equitable Holdings directors sell shares amid mixed institutional holdings changes

Equitable Holdings directors sell shares amid mixed institutional holdings changes

Two directors of Equitable Holdings sold shares recently, with Bertram L. Scott selling 2,780 shares and Craig C. MacKay selling 2,000 shares. Meanwhile, institutional investors showed mixed activity: Engineers Gate Manager LP drastically cut its hol...

Market News
Neutral
2 hours ago
Greenland mining and chip ETFs soar on new security deal and AI optimism

Greenland mining and chip ETFs soar on new security deal and AI optimism

Shares of Greenland-linked mining companies surged following a new U.S.-Denmark-Greenland security agreement that boosted investor interest in Greenland's mineral resources. Greenland Mines Ltd. jumped over 229%, while Critical Metals Corp. rose near...

Market News
Bullish
2 hours ago
Biotech stocks and leveraged ETFs lead market declines amid volatile trading and clinical news.

Biotech stocks and leveraged ETFs lead market declines amid volatile trading and clinical news.

Biotech stocks and leveraged ETFs were the biggest losers in the market, with Cue Biopharma dropping 23.7% despite positive Phase 2 clinical results. Leveraged ETFs tied to AMD, Strategy, and Novo Nordisk also saw sharp declines due to their daily-re...

Market News
Bearish
2 hours ago
Priority Technology to go private in $1.6B deal led by CEO, stock downgraded to Hold amid fair value probe.

Priority Technology to go private in $1.6B deal led by CEO, stock downgraded to Hold amid fair value probe.

Priority Technology Holdings is being taken private in a $1.6 billion deal led by its Chairman and CEO, Thomas Priore. The acquisition price is $8.05 per share, matching the analyst price target set by Lake Street, which downgraded the stock to 'Hold...

Company Fundamentals
Neutral
3 hours ago
General Mills Q3 2026 EPS expected to drop 16.3% amid lower revenue forecast

General Mills Q3 2026 EPS expected to drop 16.3% amid lower revenue forecast

General Mills is set to report its Q3 2026 earnings with an expected 16.3% decline in earnings per share to $0.72 and revenue forecast around $4.35 billion, down from last year. Despite these declines, the company reaffirmed its full-year adjusted EP...

Company Fundamentals
Bearish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App